HighMark Wealth Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3K | Hold |
80
| – | – | 0.01% | 281 |
|
|
2025
Q1 | $12.6K | Hold |
80
| – | – | 0.01% | 247 |
|
|
2024
Q4 | $12.6K | Hold |
80
| – | – | 0.01% | 257 |
|
|
2024
Q3 | $14.2K | Hold |
80
| – | – | 0.01% | 245 |
|
|
2024
Q2 | $13.5K | Hold |
80
| – | – | 0.01% | 237 |
|
|
2024
Q1 | $13.3K | Hold |
80
| – | – | 0.01% | 237 |
|
|
2023
Q4 | $13.2K | Hold |
80
| – | – | 0.01% | 234 |
|
|
2023
Q3 | $12.5K | Hold |
80
| – | – | 0.01% | 236 |
|
|
2023
Q2 | $12.5K | Hold |
80
| – | – | 0.01% | 233 |
|
|
2023
Q1 | $13K | Hold |
80
| – | – | 0.01% | 260 |
|
|
2022
Q4 | $12.8K | Hold |
80
| – | – | 0.01% | 221 |
|
|
2022
Q3 | $11K | Hold |
80
| – | – | 0.01% | 228 |
|
|
2022
Q2 | $12K | Hold |
80
| – | – | 0.01% | 218 |
|
|
2022
Q1 | $13K | Buy |
+80
| New | +$13K | 0.01% | 222 |
|